Trial · NCT03827239
Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity
NCT03827239, Not applicable, Terminated, University of Prince Edward Island
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity. Trials, record NCT03827239. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03827239
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity
- NCT number
- NCT03827239
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 6 participants, actual
- Lead sponsor
- University of Prince Edward Island
- Conditions
- Sedentary Lifestyle, Insulin Sensitivity, Glucose Metabolism
- Interventions
- Activity/Moderate Exercise
- First posted
- 2019-02-01
- Last updated
- 2021-01-29
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Insulin levels | Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days | The change in blood insulin levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology). |
| Primary | Change in concentration of C-peptide | Pre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing days | The change in blood C-peptide levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology). |
| Primary | Changes in blood glucose levels | Baseline and every 30-60 minutes over 3 hours (6 timepoints per test day) | Blood glucose levels will be determined at pre-prandial baseline and over the following 3-hour testing period using hand-held blood glucose meters. |
| Primary | Change in metabolomic response to a test meal | Pre-prandial and 3-hours post test meal through study completion | Targeted metabolomics analysis of approximately 139 metabolites in blood serum by LC-MS/MS to generate a metabolomic profile in response to a high-fat and high-carbohydrate test meal. Metabolites to be determined are categorized as biogenic amines, amino acids, histidines, carboxylic acids, acylcarnitines, glycerophospholipids and organic acids. |
| Secondary | Immediate effects of short-term sedentary behaviour on cognitive function | 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion | Assessing cognitive abilities using the Stroop Test. |
| Secondary | Immediate effects of short-term sedentary behaviour on cognitive function | 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion | Assessing cognitive abilities using the Iowa Trail Making Test. |
| Secondary | Immediate effects of short-term sedentary behaviour on cognitive function | 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion | Assessing cognitive abilities using the Digit-Span test. |
| Secondary | Immediate effects of short-term sedentary behaviour on cognitive function | 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion | Assessing cognitive abilities using the N-back test. |
| Secondary | Immediate effects of short-term sedentary behaviour on cognitive function | 3 hours post-activity (sedentary behaviour or exercise) on test days through study completion | Assessing cognitive abilities using the Flankers test. |
| Secondary | Gene expression levels in isolated PBMC populations | Pre-prandial and 3 hours post-prandial on on test days through study completion | Determining changes in gene expression in pathways associated with RAGE signalling. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Secondary outcome | ConductCognition |
| 2-Back Task | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03827239
GET https://conductscience.org/api/trials/v1/NCT03827239/registered